Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1. Years Considered for the Study
       3.2. Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1. Secondary Data
        1.1.1. Key Data from Secondary Sources
       1.2. Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Global Glaucoma Treatment Market Variables, Trends
  • Scope
      1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances
    
• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Glaucoma Treatment Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Global Glaucoma Treatment Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Global Glaucoma Treatment Market, By Indication Historical Analysis and Forecast 2020-2027 (USD Million)
  •   1. Open Angle Glaucoma
      2. Closed Angle Glaucoma
      3. Secondary Glaucoma
      4. Congenital Glaucoma
      5. Others
    
• 8.   Global Glaucoma Treatment Market, By Drug Class Historical Analysis and Forecast 2020-2027 (USD Million)
  •   1. Prostaglandin Analogs
      2. Beta Blockers
      3. Alpha Agonist
      4. Carbonic Anhydrase Inhibitors
      5. Others
    
• 9.   North America Glaucoma Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
         2.1. U.S.A
       2.2. Canada
       2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2020-2027
    
• 10.   Latin America Glaucoma Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       2.1. Brazil
       2.2. Venezuela
       2.3. Argentina
       2.4. Rest of Latin America
      3. Market Size (USD Million) Forecast for Latin America 2020-2027
    
• 11.   Europe Glaucoma Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       2.1. Germany
        2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2020-2027
    
• 12.   Asia Pacific Glaucoma Treatment Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
    
• 13.   Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
       2.1. Saudi Arabia
       2.2. UAE
       2.3. South Africa
       2.4. Egypt
      3. Market Size (USD Million) Forecast for MEA 2020-2027
    
• 14.   Market Share Analysis and Competitive Landscape
  •   1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
    
• 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
  •    1. Aerie Pharmaceuticals Inc.
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. Akorn, Incorporated
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
       3. Abbvie Inc. (Allergan Plc)
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. Bausch Health (Bausch
    
• 16.  Lomb Incorporated).
  •    15.4.1. Company Overview
       15.4.2. Product Portfolio
       15.4.3. SWOT Analysis
       15.4.4. Financial Overview
       15.4.5. Strategic Overview
      15.5. Inotek Pharmaceuticals
       15.5.1. Company Overview
       15.5.2. Product Portfolio
       15.5.3. SWOT Analysis
       15.5.4. Financial Overview
       15.5.5. Strategic Overview
        15.6. MerckCo., Inc.
       15.6.1. Company Overview
       15.6.2. Product Portfolio
       15.6.3. SWOT Analysis
       15.6.4. Financial Overview
       15.6.5. Strategic Overview
      15.7. Novartis AG
       15.7.1. Company Overview
       15.7.2. Product Portfolio
       15.7.3. SWOT Analysis
       15.7.4. Financial Overview
       15.7.5. Strategic Overview
       15.8. Pfizer Inc.
       15.8.1. Company Overview
       15.8.2. Product Portfolio
       15.8.3. SWOT Analysis
       15.8.4. Financial Overview
       15.8.5. Strategic Overview
        15.9. Santen Pharmaceutical Co., Ltd.
       15.9.1. Company Overview
       15.9.2. Product Portfolio
       15.9.3. SWOT Analysis
       15.9.4. Financial Overview
       15.9.5. Strategic Overview
    
• 17.   Pre and Post COVID-19 Impact
  •   16.1. Positive influence on the healthcare industry
      16.2. The financial disruption of the manufacturing sector
      16.3. Impact of COVID-19 on emerging companies
      16.4. Significant mandates in the healthcare regulations initiated by administrations
      16.5. The overall economic slowdown of the developing and developed nations
    
• 18.   FutureWise SME Key Takeaway Points for Client